- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06312592
GBV Prevention, Mitigation, and Response in Colombia
Owning Rights and Protection: GBV Prevention, Mitigation, and Response in Colombia
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bogotá, Colombia
- Los Andes University
-
Contact:
- Arturo Harker Roa, PhD
-
Principal Investigator:
- Arturo Harker Roa, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Woman
- At least 18 years of age
- At risk of gender based violence (GBV) or ever experienced GBV
- Have a migratory permit (for migrants/refugees)
- Colombian or Venezuelan, living in Colombia for at least six months
- Hold an entrepreneur profile registered with HIAS (the implementing partner).
Exclusion Criteria:
- Man or does not self identify as a woman
- Less than 18 years old
- Not at risk of GBV and never experienced GBV
- Does not have a migratory permit
- Not Colombian or Venezuelan
- Living in Colombia for less than six months
- No entrepreneur profile registered with HIAS (the implementing partner).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Receives the Entrepreneurship School with Gender Lens intervention.
Participants receive a general training with six modules focused on business modeling and female empowerment for the participants.
It is targeted for women who are forcibly displaced people, including refugees, and who are survivors or at risk of Sexual or Gender Based Violence.
Each women entrepreneur, participates in individual mentoring sessions to build their business plan after the training and receives $800 start-up capital for their business plan.
For at least a year, entrepreneurs will have a follow-up to promote their business scale up, including how to formalize their business in the market, how to define new strategies, and how to answer to the market's evolving requirements.
Additionally, the participants receive an extensive training in gender aspects that have been identified as relevant to promote women's empowerment.
The intervention also includes mental health content.
|
The Entrepreneurship School with Gender Lens (ESGL) is an approach that targets gender based violence survivors and women at-risk to help them develop business ideas, access needed support for the prevention of and response to GBV, exploitation and trafficking, and improve participants' overall self-reliance. Participants will go through a general business curriculum, work on business plans and learn gender issues and ways to mitigate GBV risks. Upon training completion, participants are eligible to pitch their business idea to a panel of experts and receive $800 of seed capital. They will also receive follow-up business advisory support for at least six months, focusing on access to markets and finance and building support networks, in order to continue building self-reliance. The ESGL will also include a mental health and psychosocial support module. |
No Intervention: Control group
Does not receive the Entrepreneurship School with Gender Lens intervention the Entrepreneurship School with Gender Lens intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-Reliance Index
Time Frame: Past three months
|
The SRI is a measure of refugee self-reliance, created by the Refugee Self-Reliance Initiative.
The final score is calculated using 12 domains of self-reliance, including the health-related domains of healthcare access and health status.
SRI scores may assume a value from 1 to 5, with 5 indicating greater self-reliance.
|
Past three months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Health Questionnaire (PHQ-9)
Time Frame: Past two weks
|
9-item measure of depression.
The score may assume a value from 0 to 27, with higher scores signaling greater depressive symptomology.
|
Past two weks
|
Brief Scale of Resilient Strategies
Time Frame: Last three months
|
4-item measure of resilience.
The score may assume a value from 4 to 20, with higher scores signaling greater resilience.
|
Last three months
|
Multidimensional Women's Empowerment Index
Time Frame: Last 3 months
|
Assesses women's resources, domestic decision making, decision making on personal matters, and achievements.
Items will be assessed separately.
|
Last 3 months
|
GBV perceived risk
Time Frame: Last 3 months
|
Three questions measuring self-reported perceptions of feeling supported by the community, feeling useful, and feeling controlled by one or more people.
Items will be assessed separately.
|
Last 3 months
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FWA00015367
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Decision Making
-
Massachusetts General HospitalUnknownDecision Making | Video Decision AidsUnited States
-
Boston CollegeCompleted
-
Instituto Tecnologico y de Estudios Superiores...Completed
-
Brigham and Women's HospitalCompleted
-
University of ZurichPfizerCompletedDecision MakingSwitzerland
-
University Hospital, Clermont-FerrandCompleted
-
Umraniye Education and Research HospitalCompleted
-
University of UtahNational Institutes of Health (NIH)Completed
-
University of PittsburghRecruiting
-
National Human Genome Research Institute (NHGRI)Completed
Clinical Trials on Entrepreneurship School with Gender Lens
-
The Hong Kong Polytechnic UniversityHarvard Medical School (HMS and HSDM); Chinese University of Hong KongUnknown
-
London School of Hygiene and Tropical MedicineDepartment for International Development, United Kingdom; University of Witwatersrand... and other collaboratorsCompletedHIV Infections | Gender Based ViolenceSouth Africa
-
The Hong Kong Polytechnic UniversityCompletedEffects of Blue-light Blocking Lens on Visual Functions
-
Pete Kollbaum, OD, PhDAlcon ResearchCompletedMyopia | AsthenopiaUnited States
-
Sun Yat-sen UniversityWest China Hospital; Chongqing Medical University; Shanghai General Hospital,... and other collaboratorsActive, not recruitingGlaucoma, Angle-ClosureChina
-
Rassoul Akram HospitalCompletedGlaucoma | CataractIran, Islamic Republic of
-
Johnson & Johnson Vision Care, Inc.CompletedVision Satisfaction in Bright LightSpain, United Kingdom
-
Oslo University HospitalUnknownIntraocular Lens DislocationNorway
-
Louis TongSingapore Eye Research Institute; SEED Company Pte LtdCompleted
-
Omega OphthalmicsCompleted